In vivo anticancer activity of vanillin semicarbazone

Objective:To evaluate the anticancer activity of vanillin semicarbazone(VSC) against Ehrlich ascites carcinoma(EAC) cells in Swiss albino mice.Methods:The compound VSC at three doses(5, 7.5 and 10 mg/kg i.p.) was administered into the intraperitoneal cavity of the EAC inoculated mice to observe its efficiency by studying the cell growth inhibition, reduction of tumour weight,enhancement of survival time as well as the changes in depleted hematological parameters. Allsuch parameters were also studied with a known standard drug bleomycin at the dose of 0.3 mg/kg(i.p.).Results:Among the doses studied, 10 mg/kg(i.p.) was found to be quite comparable in potency to that of bleomycin at the dose of 0.3 mg/kg(i.p.). The host toxic effects of VSC was found to be negligible.Conclusions:It can be concluded that VSC can therefore be considered as potent anticancer agent.

Hepatoprotective effect of acetone semicarbazone on Ehrlich ascites carcinoma induced carcinogenesis in experimental mice

Objective:To determine the hepatoprotective effect of acetone semicarbazone(ASC)in vivo in normal and Ehrlich ascites carcinoma(EAC)bearing male Swiss albino mice.Methods:Druginduced changes in biochemical and behavioral parameters at dose of 2.0 mg/kg body weight for14 d and nullifying the toxicity induced by EAC cells were studied.The histopathology studies of the protective effects of ASC on vital organs were also assessed.Results:The administration of ASC made insignificant changes in body weight and behavioral(salivation,diarrhea,muscular numbness)changes during treatment period due to minor toxicity were minimized after the treatment in normal mice.The biochemical parameters,including serum glutamate pyruvate transaminase,glutamate oxaloactate transaminase,alkaline phosphatase,serum glucose,cholesterol,urea,triglyceride and billirubin changed modestly in normal mice receiving ASC.Though the treatment continued,these values gradually decreased to normal level after the treatment.In EAC bearing mice,the toxic effects due to EAC cells in all cases were nullified by treatment with the ASC.Significant abnormalities were not detected in histology of the various organs of the normal mice treated with ASC.Conclusions:ASC can,therefore,be considered safe in formulating novel anticancer drug,as it exhibits strong protective effect against EAC cell bearing mice.

In vivo Anticancer Activities of Benzophenone Semicarbazone against Ehrlich Ascites Carcinoma Cells in Swiss Albino Mice

Objective Benzophenone semicarbazone(BSC) was synthesized and characterized to identify compounds with anticancer activities. Methods Anticancer activities were studied against Ehrlich Ascites Carcinoma(EAC) cells in Swiss albino mice by monitoring parameters such as tumor weight measurement,survival time of tumor bearing mice,tumor cell growth inhibition,and so on.Some hematological parameters,such as red blood cells,white blood cells,and hemoglobin content,were also measured. Results The results showed that BSC has a positive effect against EAC cells.An assessment was conducted by comparing these results with those obtained using the standard drug bleomycin. Conclusions The BSC compound can be considered as a potent anticancer agent.